Dear all, Please find attached Brenntag's press release regarding the exclusive distribution agreement for KRONOS specialty Titanium Dioxide grades marketed into the Pharma, Personal Care, and Food and Nutrition industries in ...
Dear all, Please find attached Brenntag's press release regarding the exclusive sales and marketing distribution partnership of Brenntag GmbH and INABATA France SAS for INABATA's cosmetic actives ingredients in Germany, Austria and Switzerland (DACH). For further information ...
European Association of E-Pharmacies (EAEP)
Dresden / Germany (ots) - Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health - especially in the pharma industry. This is why quality ...
Dear all, Please find attached a press release of Brenntag regarding the distribution of Corbion´s newly launched range of ESTERLAC (Trademark) emulsifiers and surfactants to cosmetics customers in key European markets. For ...
Basel, Switzerland (ots/PRNewswire) - FOR EX-US MEDICAL AND TRADE MEDIA ONLY - T-cell prolymphocytic leukaemia is an extremely rare and aggressive T-cell leukaemia, with very limited effective treatment options1,2 - Tinostamustine is in very early phase clinical trials to investigate it as a potential future ...
Munich, Germany (ots) - Dr Andreas Seidl, hired as new Chief Operating Officer and member of the Executive Board, will be responsible for managing R&D operations as well as quality and regulatory, logistics and intellectual property of LEUKOCARE AG. He will assume his new role on April 1, 2019. Munich-based ...
Frankfurt am Main/Copenhagen (ots) - TTP AG, Frankfurt/Main and its subsidiary TTP France S.A.S. are now also acquiring NNE S.A.S., the French engineering arm of the Danish company NNE A/S with 87 employees at the pharmaceutical industry sites in Paris, Lyon and Chartres. Three weeks ago, TTP AG and NNE A/S ...
Hamburg, Germany (ots) - Data recently published in Clinical Cancer Research (http://ots.de/0ZGZkf) the advantages of using an ultra-high sensitivity test for detection of mutations which may predict therapeutic efficacy for hepatocellular carcinoma (HCC). Sysmex Inostics' OncoBEAM technology, a highly clinically ...
Frankfurt am Main / Copenhagen (ots) - TTP AG, Frankfurt/Main and it's subsidiary TTP GmbH, has signed an agreement with the Danish NNE A/S in Copenhagen for the purchase of three NNE subsidiaries based in Switzerland, Germany and Belgium. TTP AG is an operational holding company specialising in production-related engineering services for the process industry. It is ...
Hamburg, Germany (ots) - Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the important clinical value of blood-based ctDNA mutation testing to ...
Melsungen/Johannesburg (ots) - On 30 June 2016, B. Braun Medical, the South African subsidiary of the German B. Braun Group, completed its acquisition of Dismed Pharmaceutical (Pty) Ltd and Dismed Criticare (Pty) Ltd, both out of business rescue. With over 600 employees in South Africa, B. Braun specialises in the ...
European Society for Medical Oncology (ESMO)
Lugano, Switzerland (ots) - The European Society for Medical Oncology, the pan-European association representing medical oncologists in Europe and beyond, has announced that it will be organising an annual Congress in Europe from 2016. A record 19,809 participants from 134 countries gathered at ESMO 2014 in Madrid to hear the results of trials which included ...
Eckert & Ziegler Strahlen und Medizintechnik AG
Berlin (ots) - Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is engaging with a USA based biotech company to become a contract manufacturer for a new type of cancer treatment and is creating a new production plant for this purpose at its Braunschweig location with financial support provided by the customer. The cooperation enfolds a brand-new ...
Ingelheim, Germany (ots/PRNewswire) - - Results from the LUX-Head & Neck 1 study show afatinib* significantly delayed tumour growth versus chemotherapy in patients following failure of their previous treatment, reducing the risk for disease progression by 20% - Head and neck cancer has a very poor prognosis with no ...
Bad Boll/Eckwälden (ots) - Dr. Hauschka, a brand marketed by the traditional German company WALA Heilmittel GmbH, is now able to boost its presence on the UK market. A newly established subsidiary, WALA UK Ltd., which is based in Oxfordshire near London, will be marketing and distributing the premium natural and organic cosmetics products as of 1 January. Dr. Hauschka enthusiasts will be able to find a wide range of ...
Bad Homburg (ots) - Q1-3 2011: - Sales EUR 12.1 billion, +2% at actual rates, +5% in constant currency - EBIT EUR 1,862 million, +5% at actual rates, +9% in constant currency - Net income EUR 565 million, +14% at actual rates, +17% in constant currency - Fresenius improves 2011 earnings1 outlook of 15% ...
Ingelheim, Germany (ots) - For scientific media outside the USA, Canada and Japan Boehringer Ingelheim announced today that it is undertaking a new initiative in the treatment of heart attack (ST-segment elevation myocardial infarction or STEMI). The company will sponsor a new clinical trial known as ...
Bensberg (ots) - Girindus, with core competencies in process development, scale up and manufacture of innovative drug and cosmetic actives, sees a significant increase in demand for its commercial oligonucleotide production capabilities in the USA and Europe. "Our know-how and our technical expertise in the area of oligonucleotide research, development and manufacturing has been validated by an increased market ...
Fresenius Medical Care AG & Co. KGaA
Bad Homburg, Germany (ots) - Summary Full Year 2003: Company met or exceeded financial targets for 2003 and will propose 7th consecutive dividend increase Net Revenues $ 5,528 million + 9% Operating income (EBIT) $ 757 million + 9% Net income $ 331 million + 14% Operating Cash Flow $ ...
Bad Homburg (ots) - - Sales: + 3 % to Euro 7.5 billion currency-adjusted: + 9 % - EBIT: + 10 %* to Euro 837 million - Net income: + 44 %* to Euro 134 million - Dividend: + 10 % to Euro 1.14 per ordinary share and Euro 1.17 per preference share The Fresenius health care group increased sales in the 2002 financial year by a plus ...
